This statistic depicts the proportion of select types of cell therapy studies being studied globally as of 2018, by region. According to the data, 50 percent of cell therapies being investigated in the U.S. were CAR-T cell therapies.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Deloitte. (January 22, 2019). Share of select types of cell therapy studies being conducted globally as of September 2018, by region [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 25, 2026, from /statistics/973333/cell-therapy-studies-globally-by-region-and-type/
Deloitte. "Share of select types of cell therapy studies being conducted globally as of September 2018, by region ." Chart. January 22, 2019. ÌÇÐÄÆƽâ°æ. Accessed July 25, 2026. /statistics/973333/cell-therapy-studies-globally-by-region-and-type/
Deloitte. (2019). Share of select types of cell therapy studies being conducted globally as of September 2018, by region . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 25, 2026. /statistics/973333/cell-therapy-studies-globally-by-region-and-type/
Deloitte. "Share of Select Types of Cell Therapy Studies Being Conducted Globally as of September 2018, by Region ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 22 Jan 2019, /statistics/973333/cell-therapy-studies-globally-by-region-and-type/
Deloitte, Share of select types of cell therapy studies being conducted globally as of September 2018, by region ÌÇÐÄÆƽâ°æ, /statistics/973333/cell-therapy-studies-globally-by-region-and-type/ (last visited July 25, 2026)
Share of select types of cell therapy studies being conducted globally as of September 2018, by region [Graph], Deloitte, January 22, 2019. [Online]. Available: /statistics/973333/cell-therapy-studies-globally-by-region-and-type/
